Raheleh Salari, Ph.D
Login to view DISC.Raheleh Salari is the Vice President of Precision Oncology at Tempus AI, leading R&D for next-generation liquid biopsy platforms. A graduate of Stanford University, she previously spearheaded the creation of Signatera at Natera, establishing the industrys first personalized test for molecular recurrence monitoring, which became a new gold standard.
She is passionate about harnessing AI and multi-modal diagnostics to improve global cancer outcomes. Raheleh is an engaged leader in her field, actively participating in conversations with other leading voices to shape the future of Life Sciences and is focused on growing her team to enhance patient-centric technology.
Unique fact: She was a driving force behind the research, development, and validation of the industrys first personalized Minimal Residual Disease (MRD) test.
Read the full overview →How Raheleh shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Raheleh cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Tempus AI Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.